Company News
Morepen Enters U.S. Prescription Generics Market
Morepen Laboratories launched Desloratadine Tablets USP, 5 mg, its first U.S. prescription generic product, via subsidiary Morepen Bio Inc.
The company has submitted its first ANDA to the U.S. FDA for
